Rapport Therapeutics Inc (RAPP)
EBITDA Growth
-47.20%
TTM · Period ending:
RAPP EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-47.20%period ending
Latest reported-47.20%period ending
RAPP TTM EBITDA YoY % (-137.18% → -47.20%)
Year-over-year change
High-resolution chart · PNG
RAPP ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -47.2021% | |
| -31.5483% | |
| -50.922% | |
| -50.9123% | |
| -66.835% | |
| -98.445% | |
| -137.1798% |